Alkermes CEO: Good Time to Make Meds

Tuesday, 19 Jun 2012 | 2:45 PM ET

Richard Pops, Alkermes CEO, says it's a good time to be developing new medicines if you have access to capital. "Biotech industry is the lifeblood-- the wells spring-- of new innovation for the big pharmaceutical companies," he says.